UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exploring the in vitro stability of insulin degrading enzyme as a potential biomarker for neurocognitive disorders and Alzheimer's disease risk

Practical laboratory medicine, 2024-05, Vol.40, p.e00400-e00400, Article e00400

2024

Volltextzugriff (PDF)

Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease

Nuclear medicine and biology, 2012-05, Vol.39 (4), p.484-501

2012

Volltextzugriff (PDF)

[ 11C]PIB-amyloid binding and levels of Aβ40 and Aβ42 in postmortem brain tissue from Alzheimer patients

Neurochemistry international, 2009-05, Vol.54 (5), p.347-357

2009

Volltextzugriff (PDF)

Serotonin 1B receptor density mapping of the human brainstem using positron emission tomography and autoradiography

Journal of cerebral blood flow and metabolism, 2022-04, Vol.42 (4), p.630-641

2022

Volltextzugriff (PDF)

Correlations between insulin-degrading enzyme and metabolic markers in patients diagnosed with type 2 diabetes, Alzheimer’s disease, and healthy controls: a comparative study

Endocrine, 2024-05, Vol.84 (2), p.450-458

2024

Volltextzugriff (PDF)

Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice

The Journal of pharmacology and experimental therapeutics, 2006-04, Vol.317 (1), p.30-36

2006

Volltextzugriff (PDF)

Associations between the Use of Metformin and Behavioral and Psychological Symptoms in Patients with Alzheimer´s Disease, and Type 2 Diabetes Mellitus - A Register-based Study

Current Alzheimer research, 2023-01, Vol.20 (2), p.109-119

2023

Volltextzugriff (PDF)

Increased levels of insulin-degrading enzyme in patients with type 2 diabetes mellitus

Endocrine, 2022, Vol.77 (3), p.561-565

2022

Volltextzugriff (PDF)

Distribution and levels of 5-HT1B receptors in anterior cingulate cortex of patients with bipolar disorder, major depressive disorder and schizophrenia – An autoradiography study

European neuropsychopharmacology, 2017-05, Vol.27 (5), p.504-514

2017

Volltextzugriff (PDF)

Amyloid binding properties of curcumin analogues in Alzheimer’s disease postmortem brain tissue

Neuroscience letters, 2016-09, Vol.630, p.183-188

2016

Volltextzugriff (PDF)

In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [18F]MNI-659

Brain research, 2019-05, Vol.1711, p.140-145

2019

Volltextzugriff (PDF)

Distribution and levels of 5-HT 1B receptors in anterior cingulate cortex of patients with bipolar disorder, major depressive disorder and schizophrenia - An autoradiography study

European neuropsychopharmacology, 2017-05, Vol.27 (5), p.504-514

2017

Volltextzugriff (PDF)

Specific uptake of an amyloid-β protofibril-binding antibody-tracer in AβPP transgenic mouse brain

Journal of Alzheimer's disease, 2013-01, Vol.37 (1), p.29-40

2013

Volltextzugriff (PDF)

Effect of subchronic galantamine treatment on neuronal nicotinic and muscarinic receptor subtypes in transgenic mice overexpressing human acetylcholinesterase

Neuropharmacology, 2004-09, Vol.47 (4), p.558-571

2004

Volltextzugriff (PDF)

Neuronal nicotinic and muscarinic receptor subtypes at different ages of transgenic mice overexpressing human acetylcholinesterase

Neuroscience letters, 2003-04, Vol.340 (2), p.148-152

2003

Volltextzugriff (PDF)

[C-11]PIB-amyloid binding and levels of A beta 40 and A beta 42 in postmortem brain tissue from Alzheimer patients

Neurochemistry international, 2009, Vol.54 (5-6), p.347

2009

Volltextzugriff (PDF)

Early changes in Aβ levels in the brain of APPswe transgenic mice—Implication on synaptic density, α7 neuronal nicotinic acetylcholine- and N-methyl- d-aspartate receptor levels

Molecular and cellular neuroscience, 2005-10, Vol.30 (2), p.218-227

2005

Volltextzugriff (PDF)

Early changes in Abeta levels in the brain of APPswe transgenic mice--implication on synaptic density, alpha7 neuronal nicotinic acetylcholine- and N-methyl-D-aspartate receptor levels

Molecular and cellular neuroscience, 2005-10, Vol.30 (2), p.218-227

2005

Volltextzugriff (PDF)

P1-092: Early effects of beta-amyloid on synapses, alpha7 nAChRs, NMDARs and signal transduction in APPswe transgenic mice

Alzheimer's & dementia, 2006-07, Vol.2 (3), p.S122-S122

2006

Volltextzugriff (PDF)

P1-058: Different effects of L-(-)-nicotine on beta-amyloid pathology in the brain of two transgenic mouse models

Alzheimer's & dementia, 2006-07, Vol.2 (3), p.S111-S112

2006

Volltextzugriff (PDF)

Upregulation of Neuronal Nicotinic Receptor Subunits α4,β2,and α7 in Transgenic Mice Overexpressing Human Acetylcholinesterase

Journal of molecular neuroscience, 2002, Vol.18 (3), p.211-222

2002

Volltextzugriff (PDF)

[(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients

Neurochemistry international, 2009-05, Vol.54 (5-6), p.347-357

2009

Volltextzugriff (PDF)

Upregulation of neuronal nicotinic receptor subunits [alpha]4, [beta]2, and [alpha]7 in transgenic mice overexpressing human acetylcholinesterase

Journal of molecular neuroscience, 2002-06, Vol.18 (3), p.211

2002

Volltextzugriff (PDF)

Expression of nicotinic achetylcholine receptor subunits in ache-transgenic mice

Neurobiology of aging, 2000-05, Vol.21, p.153-153

2000

Volltextzugriff (PDF)

Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase

Journal of molecular neuroscience, 2002-06, Vol.18 (3), p.211-222

2002

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(74)

Sprache

Englisch
(74)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exploring the in vitro stability of insulin degrading enzyme as a potential biomarker for neurocognitive disorders and Alzheimer's disease risk

Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease

[ 11C]PIB-amyloid binding and levels of Aβ40 and Aβ42 in postmortem brain tissue from Alzheimer patients

Serotonin 1B receptor density mapping of the human brainstem using positron emission tomography and autoradiography

Correlations between insulin-degrading enzyme and metabolic markers in patients diagnosed with type 2 diabetes, Alzheimer’s disease, and healthy controls: a comparative study

Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice

Associations between the Use of Metformin and Behavioral and Psychological Symptoms in Patients with Alzheimer´s Disease, and Type 2 Diabetes Mellitus - A Register-based Study

Increased levels of insulin-degrading enzyme in patients with type 2 diabetes mellitus

Distribution and levels of 5-HT1B receptors in anterior cingulate cortex of patients with bipolar disorder, major depressive disorder and schizophrenia – An autoradiography study

Amyloid binding properties of curcumin analogues in Alzheimer’s disease postmortem brain tissue

In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [18F]MNI-659

Distribution and levels of 5-HT 1B receptors in anterior cingulate cortex of patients with bipolar disorder, major depressive disorder and schizophrenia - An autoradiography study

Specific uptake of an amyloid-β protofibril-binding antibody-tracer in AβPP transgenic mouse brain

Effect of subchronic galantamine treatment on neuronal nicotinic and muscarinic receptor subtypes in transgenic mice overexpressing human acetylcholinesterase

Neuronal nicotinic and muscarinic receptor subtypes at different ages of transgenic mice overexpressing human acetylcholinesterase

[C-11]PIB-amyloid binding and levels of A beta 40 and A beta 42 in postmortem brain tissue from Alzheimer patients

Early changes in Aβ levels in the brain of APPswe transgenic mice—Implication on synaptic density, α7 neuronal nicotinic acetylcholine- and N-methyl- d-aspartate receptor levels

Early changes in Abeta levels in the brain of APPswe transgenic mice--implication on synaptic density, alpha7 neuronal nicotinic acetylcholine- and N-methyl-D-aspartate receptor levels

P1-092: Early effects of beta-amyloid on synapses, alpha7 nAChRs, NMDARs and signal transduction in APPswe transgenic mice

P1-058: Different effects of L-(-)-nicotine on beta-amyloid pathology in the brain of two transgenic mouse models

Upregulation of Neuronal Nicotinic Receptor Subunits α4,β2,and α7 in Transgenic Mice Overexpressing Human Acetylcholinesterase

[(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients

Upregulation of neuronal nicotinic receptor subunits [alpha]4, [beta]2, and [alpha]7 in transgenic mice overexpressing human acetylcholinesterase

Expression of nicotinic achetylcholine receptor subunits in ache-transgenic mice

Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase

Suchergebnisse filtern